SCHEMBL10526463

SCHEMBL10526463

CC1CC(=O)Nc2nc(C#N)c3ncccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ ELANE P08246 5/20 0.33
▸ GSK3B P49841 2/20 0.33
▸ CCNB2 O95067 2/20 0.33
▸ CDK1 P06493 2/20 0.33
▸ CCNB1 P14635 2/20 0.33
▸ CCNB3 Q8WWL7 2/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ GSK3A P49840 1/20 0.33
▸ CCNA1 P78396 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ SYK P43405 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10526290 0.86 TNKS (0.36) ALDH1A1ELANEGSK3BCCNB2CDK1
SCHEMBL10525166 0.83 CCNB2 (0.37) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10527852 0.81 KDM4E (0.34) ALDH1A1GSK3BCCNB2CDK1CCNB1
SCHEMBL10527803 0.81 DHFR (0.35) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10527276 0.80 CCNB2 (0.38) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10526812 0.80 GSK3B (0.35) ALDH1A1GSK3BCCNB2CDK1CCNB1
SCHEMBL10524717 0.80 KAT2B (0.38) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10526729 0.79 IDO1 (0.36) ELANESYKDDB1CRBNCREBBP
SCHEMBL10527375 0.79 KAT2B (0.37) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10525447 0.78 BRD4 (0.36) CCNA2CDK2KDM4EDDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4801590-A ANGINA, ANTICANCER, CARDIOVASCULAR DISORDERS, HEADACHES, PSORIASIS, ASTHMA, ANTICOAGULANTS BEIERSDORF AG (DE) 1989-01-31 — — US disclosed
EP-0253171-A1 Pyrido[1,8]naphthyridinones, process for their preparation and their use and compositions containing them Beiersdorf-Lilly GmbH (DE) 1988-01-20 — — EP disclosed
Send feedback